Transforming growth factors from neoplastic and nonneoplastic tissues.

PubWeight™: 3.31‹?› | Rank: Top 1%

🔗 View Article (PMID 6303865)

Published in Fed Proc on June 01, 1983

Authors

A B Roberts, C A Frolik, M A Anzano, M B Sporn

Articles citing this

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A (1986) 12.14

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med (1986) 9.86

Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A (1987) 6.43

Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci U S A (1985) 5.93

TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med (2009) 4.58

Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J Cell Biol (1990) 3.81

Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol (1986) 3.77

Epidermal growth factor and oncogenes induce transcription of the same cellular mRNA in rat fibroblasts. EMBO J (1985) 3.60

Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors. Proc Natl Acad Sci U S A (1983) 3.02

Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc Natl Acad Sci U S A (1986) 2.93

Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol (1987) 2.87

Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci U S A (1988) 2.03

The reversal of an Adriamycin induced healing impairment with chemoattractants and growth factors. Ann Surg (1986) 1.94

Hepatic processing of transforming growth factor beta in the rat. Uptake, metabolism, and biliary excretion. J Clin Invest (1987) 1.88

Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia. J Exp Med (1990) 1.83

Blockade of autocrine stimulation in simian sarcoma virus-transformed cells reverses down-regulation of platelet-derived growth factor receptors. Proc Natl Acad Sci U S A (1984) 1.80

Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. Proc Natl Acad Sci U S A (1985) 1.75

Increased secretion of type beta transforming growth factor accompanies viral transformation of cells. Mol Cell Biol (1985) 1.65

Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev (1998) 1.58

Differential responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal growth factor. Mol Cell Biol (1986) 1.57

Stimulation of glycolysis and amino acid uptake in NRK-49F cells by transforming growth factor beta and epidermal growth factor. Proc Natl Acad Sci U S A (1985) 1.51

Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis. J Vasc Res (2008) 1.42

Type beta transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged prereplicative interval. Proc Natl Acad Sci U S A (1985) 1.42

Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures. J Clin Invest (1986) 1.41

Tumor products and the hypercalcemia of malignancy. J Clin Invest (1985) 1.37

Expression of rat transforming growth factor alpha mRNA during development occurs predominantly in the maternal decidua. Mol Cell Biol (1987) 1.30

Human transforming growth factor-alpha stimulates bone resorption in vitro. J Clin Invest (1985) 1.28

Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines. J Exp Med (1988) 1.24

Smad signaling in skeletal development and regeneration. Cytokine Growth Factor Rev (2009) 1.17

Transforming and nontransforming growth factors are present in medium conditioned by fetal rat calvariae. Proc Natl Acad Sci U S A (1985) 1.16

Immunohistochemical localization of transforming growth factor-beta 1 in rats with experimental silicosis, alveolar type II hyperplasia, and lung cancer. Am J Pathol (1993) 1.14

Oestrogen receptor: a stable phenotype in breast cancer. Br J Cancer (1996) 1.13

Biology of pancreatic cancer. Gut (1991) 1.09

Transforming growth factor-beta activity in sheep lung lymph during the development of pulmonary hypertension. J Clin Invest (1990) 1.01

L-428 nodular sclerosing Hodgkin's cell secretes a unique transforming growth factor-beta active at physiologic pH. J Clin Invest (1988) 1.01

The tale of transforming growth factor-beta (TGFbeta) signaling: a soigné enigma. IUBMB Life (2009) 0.96

Production of transforming growth factor-beta activity by Ki-1 positive lymphoma cells and analysis of its role in the regulation of Ki-1 positive lymphoma growth. Am J Pathol (1988) 0.96

Accumulation, localization, and compartmentation of transforming growth factor beta during endochondral bone development. J Cell Biol (1988) 0.94

Cell-mediated co-action of transforming growth factors: incubation of type beta with normal rat kidney cells produces a soluble activity that prolongs the ruffling response to type alpha. J Cell Biol (1986) 0.92

From wavy hair to naked proteins: the role of transforming growth factor alpha in health and disease. Semin Cell Dev Biol (2014) 0.89

Endothelin-1 stimulates DNA synthesis and anchorage-independent growth of Rat-1 fibroblasts through a protein kinase C-dependent mechanism. Cell Regul (1990) 0.88

Heterogeneous engineered cartilage growth results from gradients of media-supplemented active TGF-β and is ameliorated by the alternative supplementation of latent TGF-β. Biomaterials (2015) 0.85

Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer. Br J Cancer (1994) 0.82

Leptin promotes wound healing in the oral mucosa. PLoS One (2014) 0.80

Fibulin-4 regulates expression of the tropoelastin gene and consequent elastic-fibre formation by human fibroblasts. Biochem J (2009) 0.80

Isolation of an autocrine growth factor from hepatoma HTC-SR cells. J Cell Physiol (1987) 0.79

Cell-Laden Hydrogels for Osteochondral and Cartilage Tissue Engineering. Acta Biomater (2017) 0.79

Neutralizing antibodies against transforming growth factor beta potentiate the proliferation of Ki-1 positive lymphoma cells. Further evidence for negative autocrine regulation by transforming growth factor beta. Am J Pathol (1992) 0.78

Transforming growth factor alpha and a PC12-derived growth factor induce neurites in PC12 cells and enhance the survival of embryonic brain neurons. Cell Regul (1990) 0.77

Inhibition of epidermal growth factor-induced cellular proliferation. Am J Pathol (1987) 0.77

Lowering extracellular Na+ concentration releases autocrine growth factors from renal epithelial cells. Proc Natl Acad Sci U S A (1986) 0.75

TGF-β regulation of encephalitogenic and regulatory T cells in multiple sclerosis. Eur J Immunol (2017) 0.75

Articles by these authors

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A (1986) 12.14

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A (1993) 10.82

Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature (1985) 10.13

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med (1986) 9.86

Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem (1983) 9.32

Regulation of immune responses by TGF-beta. Annu Rev Immunol (1998) 8.01

Autocrine secretion and malignant transformation of cells. N Engl J Med (1980) 7.49

Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci U S A (1987) 6.76

Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A (1987) 6.43

Autocrine growth factors and cancer. Nature (1985) 5.97

Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci U S A (1985) 5.93

New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci U S A (1981) 5.89

Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol (1999) 5.58

Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J (1999) 5.49

Human transforming growth factor-alpha: precursor structure and expression in E. coli. Cell (1984) 5.39

Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol (1987) 5.25

Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. J Immunol (1986) 5.19

Transforming growth factor-beta: biological function and chemical structure. Science (1986) 5.08

Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A (1992) 4.94

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature (1990) 4.64

Can dietary beta-carotene materially reduce human cancer rates? Nature (1981) 4.43

Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. J Biol Chem (1984) 4.20

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J Natl Cancer Inst (1999) 4.04

Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science (1987) 4.03

Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. J Biol Chem (1988) 3.91

Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol (1986) 3.77

A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta. Cell (1988) 3.72

Role of transforming growth factor-beta signaling in cancer. J Natl Cancer Inst (2000) 3.63

Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture. J Cell Physiol (1989) 3.58

Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes. J Cell Biol (1989) 3.55

Purification and initial characterization of a type beta transforming growth factor from human placenta. Proc Natl Acad Sci U S A (1983) 3.52

Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo. Science (1983) 3.51

Purification and properties of a type beta transforming growth factor from bovine kidney. Biochemistry (1983) 3.49

Role of transforming growth factor-beta in the development of the mouse embryo. J Cell Biol (1987) 3.48

Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc Natl Acad Sci U S A (1980) 3.45

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors (1993) 3.43

Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol (1986) 3.29

Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A (1995) 3.25

Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc (1976) 3.19

Transforming growth factor-beta: recent progress and new challenges. J Cell Biol (1992) 3.18

Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. J Biol Chem (1988) 3.13

Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors. Proc Natl Acad Sci U S A (1983) 3.02

Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc Natl Acad Sci U S A (1986) 2.93

Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol (1987) 2.87

Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem (2001) 2.85

Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice. J Cell Biol (1989) 2.77

Role of retinoids in differentiation and carcinogenesis. Cancer Res (1983) 2.74

Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol Cell Biol (1990) 2.73

Peptide growth factors are multifunctional. Nature (1988) 2.71

Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells. Cancer Res (1982) 2.70

Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J Immunol (1988) 2.70

Mesoderm induction in amphibians: the role of TGF-beta 2-like factors. Science (1988) 2.68

Cellular transformation by coordinated action of three peptide growth factors from human platelets. Nature (1984) 2.66

Tumor suppressor activity of the TGF-beta pathway in human cancers. Cytokine Growth Factor Rev (1996) 2.57

Aflatoxin B1: binding to DNA in vitro and alteration of RNA metabolism in vivo. Science (1966) 2.46

Peptide growth factors and inflammation, tissue repair, and cancer. J Clin Invest (1986) 2.40

Characterization of the promoter region of the human transforming growth factor-beta 1 gene. J Biol Chem (1989) 2.40

Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp Cell Res (1992) 2.38

Transforming growth factor-beta controls receptor levels for epidermal growth factor in NRK fibroblasts. Cell (1984) 2.30

Recent advances in chemoprevention of cancer. Science (1997) 2.30

Maternal rescue of transforming growth factor-beta 1 null mice. Science (1994) 2.28

Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J Clin Invest (1989) 2.28